Genie Energy (NYSE:GNE) lowered its full-year 2026 adjusted EBITDA outlook after a first quarter in which record revenue was offset by weaker retail energy margins, higher customer acquisition spending and investment in early-stage growth initiatives.
Chief Executive Officer Michael Stein said the
Today's Research Daily features new research reports on 16 major stocks, including Apple Inc., Meta Platforms, Inc., and The Procter & Gamble Company, as well as a micro-cap stock, Genie Energy Ltd..
In 1979, Genentech managed to create synthetic human insulin. Now 45 years later, biotech is a $1.77 trillion industry — up from $1.55 trillion in 2023. By 2030, that’s projected to reach close to $4 trillion.
The CNN Money Fear and Greed index remained in the "Greed" zone on Monday. U.S. stocks closed mixed on Monday, with the S&P 500 settling lower for the second straight session. All three major indices closed recorded losses last week, with the S&P 500 falling 0.26% and the blue-chip Dow declining 0.93%.
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning higher on Monday. The Dow traded up 0.08% to 38,753.49 while the NASDAQ fell 0.20% to 16,052.34. The S&P 500 also fell, dropping, 0.14% to 5,116.66.
Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday.
U.S. stocks traded lower midway through trading, with the Dow Jones index dipping over 50 points on Monday. The Dow traded down 0.16% to 38,662.09 while the NASDAQ fell 0.26% to 16,043.75. The S&P 500 also fell, dropping, 0.27% to 5,110.11.
